Multiple-Gene Sequencing Shows Clinical Relevance in Cancer-Risk Assessment

Study findings point to the clinical benefits of a multiple-Gene sequencing panel for assessing cancer risk in appropriately selected groups of patients

ESMO members: your membership includes full access to OncologyPRO Daily News, created exclusively for you by medwireNews. Sign in now to access this page.